Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Current epidemics, such as HIV or influenza, and the emergence of new threatening pathogens, such as the one causing the current coronavirus disease 2019 (COVID-19) pandemic, represent major global health challenges. While vaccination is an important part of the arsenal to counter the spread of vir...
Guardado en:
Autores principales: | Merve Cakir, Kirsten Obernier, Antoine Forget, Nevan J. Krogan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85a6dbc912814a749a2a574b6f58a119 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Xiaonan Liu, et al.
Publicado: (2021) -
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
por: Irina RUSU, et al.
Publicado: (2020) -
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
por: Carolina Moretto Carnielli, et al.
Publicado: (2018) -
Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Douglas D. Richman
Publicado: (2020) -
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
por: Zhizhen Li, et al.
Publicado: (2021)